These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 25927573)

  • 1. Drug use patterns associated with risk of non-adherence to antiretroviral therapy among HIV-positive illicit drug users in a Canadian setting: a longitudinal analysis.
    Azar P; Wood E; Nguyen P; Luma M; Montaner J; Kerr T; Milloy MJ
    BMC Infect Dis; 2015 Apr; 15():193. PubMed ID: 25927573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors linked to transitions in adherence to antiretroviral therapy among HIV-infected illicit drug users in a Canadian setting.
    Joseph B; Kerr T; Puskas CM; Montaner J; Wood E; Milloy MJ
    AIDS Care; 2015; 27(9):1128-36. PubMed ID: 25915438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors associated with optimal pharmacy refill adherence for antiretroviral medications and plasma HIV RNA non-detectability among HIV-positive crack cocaine users: a prospective cohort study.
    Hayashi K; Wood E; Kerr T; Dong H; Nguyen P; Puskas CM; Guillemi S; Montaner JS; Milloy MJ
    BMC Infect Dis; 2016 Aug; 16(1):455. PubMed ID: 27568002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychosocial factors in adherence to antiretroviral therapy among HIV-positive people who use drugs.
    Lee WK; Milloy MJ; Walsh J; Nguyen P; Wood E; Kerr T
    Health Psychol; 2016 Mar; 35(3):290-7. PubMed ID: 26690643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improvements in HIV treatment outcomes among indigenous and non-indigenous people who use illicit drugs in a Canadian setting.
    Milloy MJ; King A; Kerr T; Adams E; Samji H; Guillemi S; Wood E; Montaner J
    J Int AIDS Soc; 2016; 19(1):20617. PubMed ID: 27094914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose-response relationship between methadone dose and adherence to antiretroviral therapy among HIV-positive people who use illicit opioids.
    Lappalainen L; Nolan S; Dobrer S; Puscas C; Montaner J; Ahamad K; Dong H; Kerr T; Wood E; Milloy MJ
    Addiction; 2015 Aug; 110(8):1330-9. PubMed ID: 25940906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dispensation of antiretroviral therapy and methadone maintenance therapy at the same facility in a low-barrier setting linked to optimal adherence to HIV treatment.
    Mohd Salleh NA; Fairbairn N; Nolan S; Barrios R; Shoveller J; Richardson L; Milloy MJ
    HIV Med; 2019 Oct; 20(9):606-614. PubMed ID: 31359615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ongoing drug use and outcomes from highly active antiretroviral therapy among injection drug users in a Canadian setting.
    Krüsi A; Milloy MJ; Kerr T; Zhang R; Guillemi S; Hogg R; Montaner J; Wood E
    Antivir Ther; 2010; 15(5):789-96. PubMed ID: 20710061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and Correlates of Reporting Difficulty Taking Antiretroviral Treatment Among HIV-Positive Illicit Drug Users in Vancouver, Canada: A Longitudinal Analysis.
    Yeung B; Mohd Salleh NA; Socías E; Dong H; Shoveller J; Montaner JSG; Milloy MS
    AIDS Behav; 2019 May; 23(5):1250-1257. PubMed ID: 30284081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Initiating highly active antiretroviral therapy and continuity of HIV care: the impact of incarceration and prison release on adherence and HIV treatment outcomes.
    Palepu A; Tyndall MW; Chan K; Wood E; Montaner JS; Hogg RS
    Antivir Ther; 2004 Oct; 9(5):713-9. PubMed ID: 15535408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between hunger, adherence to antiretroviral therapy and plasma HIV RNA suppression among HIV-positive illicit drug users in a Canadian setting.
    Anema A; Kerr T; Milloy MJ; Feng C; Montaner JS; Wood E
    AIDS Care; 2014 Apr; 26(4):459-65. PubMed ID: 24015838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alcohol use and incarceration adversely affect HIV-1 RNA suppression among injection drug users starting antiretroviral therapy.
    Palepu A; Tyndall MW; Li K; Yip B; O'Shaughnessy MV; Schechter MT; Montaner JS; Hogg RS
    J Urban Health; 2003 Dec; 80(4):667-75. PubMed ID: 14709714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiretroviral adherence and HIV treatment outcomes among HIV/HCV co-infected injection drug users: the role of methadone maintenance therapy.
    Palepu A; Tyndall MW; Joy R; Kerr T; Wood E; Press N; Hogg RS; Montaner JS
    Drug Alcohol Depend; 2006 Sep; 84(2):188-94. PubMed ID: 16542797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors associated with initiation of antiretroviral therapy among HIV-positive people who use injection drugs in a Canadian setting.
    Joseph B; Wood E; Hayashi K; Kerr T; Barrios R; Parashar S; Richardson L; Dobrer S; Guillemi S; Montaner J; Milloy MJ
    AIDS; 2016 Mar; 30(6):925-32. PubMed ID: 26636927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Female gender predicts lower access and adherence to antiretroviral therapy in a setting of free healthcare.
    Tapp C; Milloy MJ; Kerr T; Zhang R; Guillemi S; Hogg RS; Montaner J; Wood E
    BMC Infect Dis; 2011 Apr; 11():86. PubMed ID: 21466704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Longitudinal Analysis of Daily Pill Burden and Likelihood of Optimal Adherence to Antiretroviral Therapy Among People Living With HIV Who Use Drugs.
    Mohd Salleh NA; Richardson L; Kerr T; Shoveller J; Montaner J; Kamarulzaman A; Milloy MJ
    J Addict Med; 2018; 12(4):308-314. PubMed ID: 29521670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired virologic response to highly active antiretroviral therapy associated with ongoing injection drug use.
    Palepu A; Tyndall M; Yip B; O'Shaughnessy MV; Hogg RS; Montaner JS
    J Acquir Immune Defic Syndr; 2003 Apr; 32(5):522-6. PubMed ID: 12679704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longitudinal Factors Associated with Used Syringe Lending Among HIV-Positive Antiretroviral Therapy-Naïve People Who Inject Drugs in a Canadian Setting.
    Blumenkrans E; Socías ME; Richardson L; Kerr T; Shoveller J; Montaner J; Milloy MJ
    AIDS Behav; 2020 Jul; 24(7):2163-2168. PubMed ID: 32026249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-intensity cannabis use and HIV clinical outcomes among HIV-positive people who use illicit drugs in Vancouver, Canada.
    Lake S; Kerr T; Capler R; Shoveller J; Montaner J; Milloy MJ
    Int J Drug Policy; 2017 Apr; 42():63-70. PubMed ID: 28336000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Longitudinal patterns of illicit drug use, antiretroviral therapy exposure and plasma HIV-1 RNA viral load among HIV-positive people who use illicit drugs.
    Liang J; Nosova E; Reddon H; Nolan S; Socías E; Barrios R; Milloy MJ
    AIDS; 2020 Jul; 34(9):1389-1396. PubMed ID: 32590435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.